Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy. - Wikidata - wikimedia - TriplyDB

Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy.

Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy.

http://www.wikidata.org/entity/Q38041388

about

Exquisite allele discrimination by toehold hairpin primers.Implementation and utilization of genetic testing in personalized medicine.Influence of CYP2D6 polymorphisms on serum levels of tamoxifen metabolites in Spanish women with breast cancer Commercial Opportunities and Ethical Pitfalls in Personalized Medicine: A Myriad of Reasons to Revisit the Myriad Genetics Saga.Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment.CYP2D6 genotype and tamoxifen activity: understanding interstudy variability in methodological quality Impact of metabolizing enzymes on drug response of endocrine therapy in breast cancer.Clinical application of pharmacogenetics: focusing on practical issues.Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing.Combining genetic variations in CYP2C9 and VKORC1 with clinical factors for warfarin dosing determination improved clinical effectiveness.Impact of a personal CYP2D6 testing workshop on physician assistant student attitudes toward pharmacogenetics.Impact of variable CYP genotypes on breast cancer relapse in patients undergoing adjuvant tamoxifen therapy.Frequency of CYP2D6 Alleles Including Structural Variants in the United States.

P2860

Q34115346-FF586ECF-690D-4307-98F5-20EB055F2E74 Q34147916-07A03C22-E008-413E-BDF7-204C96D4AA91 Q36909858-C013CCA0-86C0-4B3A-AC68-9C9741B9B0F3 Q37026028-0946C26C-A524-4411-9FAF-BE0AEE9D6926 Q37170578-C3EA1514-2E9D-4F29-9A78-50CE3A92722C Q37195587-DA189384-6A99-4056-B4D6-C986EF8FCC19 Q38103593-3D0A06EB-94B1-42C6-9B49-9E7124D5F16B Q38593942-096D568A-3CD2-4120-A379-ACC26503960F Q39282325-7B7938D9-A5F2-43AE-A910-BE5E54A8385A Q45369313-156CEDD0-D7A0-4815-816B-DA3A9EA6807F Q50531408-EAEC62DD-4FF8-4EC4-BAE1-B72D28FF8D64 Q53831501-52AB367F-E901-4F8E-BBB9-8C4ED4318E0D Q55087082-2B4BB30D-A9E2-4F6D-8339-96920D80585D

P2860

Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy.

http://www.wikidata.org/entity/Q38041388

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy.

@en

type

label

Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy.

@en

prefLabel

Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy.

@en

P1433

Q38041388-A9E25122-1F62-4A3D-974F-B07956FF2347

P1476

Q38041388-326152C1-2D7E-49DD-90B8-8245261B0F60

P2093

Q38041388-5CFBF6D4-8550-4965-9B19-8522ED263F92

Q38041388-6267F412-4622-4DE4-8288-97FC8D1A1360

Q38041388-733CD06B-B974-4807-AB62-CAE40918C32F

Q38041388-9786ADAE-AE58-4056-B9B0-4E6E89EF9E81

Q38041388-BCCBFE83-C954-4D89-ACDA-65BF128C2763

Q38041388-DEAD6BB0-F18E-42AC-AF86-88101E903E74

Q38041388-DECECC6B-F5C8-4F60-A216-6A7F1CEA6E22

Q38041388-F8F248FB-85E3-41DA-85C4-A0575BA8E7D3

P2860

Q38041388-0C8A6581-12EF-46AD-9B2D-D1737EECFFB5

Q38041388-0D3C8AAA-3966-42E6-A94F-6CD8B08DBE4D

Q38041388-0FB1FA2C-D3DE-4AE9-A299-4A38AA212B60

Q38041388-13826508-F7ED-4588-8B82-355FE2B546B0

Q38041388-14C85DC6-D969-4381-8DDD-AAC400633DC9

Q38041388-155733A4-BA67-4768-9901-F48A49C2344C

Q38041388-24172EC6-5E62-45AF-9658-F7A51D65F1F3

Q38041388-311B69E0-2D37-459D-9F2D-8EAAB4FF5B23

Q38041388-4B370ECC-F29C-4420-83CC-307CE46653D5

Q38041388-67BE4A11-93FC-4000-88DC-6AA7AFFC4CAC

P2888

Q38041388-6D9A0161-B3B5-47CF-9877-DE7A796C0287

P304

Q38041388-5106942F-BD04-4D60-A618-19E8781BC576

P31

Q38041388-7B2290D5-B9A6-4A31-A841-14702B05884B

P356

Q38041388-E5A7D36F-EF7C-4CE2-BBFD-645150DF0E55

P407

Q38041388-AE43E588-ED40-43FE-8EC1-72B1C366EFF3

P433

Q38041388-C6B4B413-EAAC-4897-BB43-B65406E11A1A

P478

Q38041388-B615A597-7CB1-42AF-84B0-304A9112E95E

P50

Q38041388-4AC16CA2-57AC-4BCE-AF0F-F0FFA1665F13

P577

Q38041388-2756E1F1-0246-4F00-82FF-3492EAD8A2D4

P5875

Q38041388-37E08315-8D52-4E1A-BDAF-C28B2741D29F

P698

Q38041388-815D9548-BFA4-4AA7-8C24-1B68F5BE1573

P921

Q38041388-e24445a9-5fa5-4df8-99ae-d5bac1336dc3

P356

P1433

Genetics in Medicine

P1476

Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy

@en

P2093

Elaine Lyon

http://www.w3.org/2001/XMLSchema#string

Glenn E Palomaki

http://www.w3.org/2001/XMLSchema#string

Julie Gastier Foster

http://www.w3.org/2001/XMLSchema#string

Kristen Reynolds

http://www.w3.org/2001/XMLSchema#string

M Fernanda Sábato

http://www.w3.org/2001/XMLSchema#string

Patrik Vitazka

http://www.w3.org/2001/XMLSchema#string

Victoria M Pratt

http://www.w3.org/2001/XMLSchema#string

working group of the Molecular ...... ry Quality Assurance Committee

http://www.w3.org/2001/XMLSchema#string

P2860

Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.

Genotype-guided tamoxifen therapy: time to pause for reflection?

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.

Molecular basis of ethnic differences in drug disposition and response.

Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative project.

Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6.

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes.

P2888

P304

990-1000

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GIM.2012.108

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230810543

http://www.w3.org/2001/XMLSchema#string

P698

22955113

http://www.w3.org/2001/XMLSchema#string

P921

medical genetics